RecruitingNot ApplicableNCT07219251

Engagement of Veterans With Lung Cancer

Engagement of Veterans With Lung Cancer (EVLC)


Sponsor

Palo Alto Veterans Institute for Research

Enrollment

194 participants

Start Date

Feb 27, 2026

Study Type

INTERVENTIONAL

Conditions

Summary

This research study will help our understanding of whether additional support for Veterans with lung cancer can improve their quality of life.


Eligibility

Min Age: 18 Years

Inclusion Criteria7

  • Veteran patients with diagnosis of any stage of lung cancer;
  • years of age or older;
  • English- or Spanish-speaking;
  • can self-administer questionnaires in English or Spanish;
  • valid telephone number;
  • receiving oncology care at participating sites;
  • currently newly diagnosed or receiving or having completed systemic anti-cancer therapy and/or radiation therapy within 12 months, defined as oral, injection, or intravenous therapy (chemotherapy, targeted therapy, or immunotherapy)

Exclusion Criteria2

  • no capacity to consent;
  • actively receiving hospice care

Interventions

BEHAVIORALLay Health Worker (LHW) Planning

Patients randomized to the LHW group will receive usual care provided by their oncology (or primary) clinical team along with an initial 30-minute telephone call with the LHW from Palo Alto, followed by weekly 15-minute phone calls (or as needed) for 6months. These calls are designed to assist with healthcare planning, symptom management, and discussions about care preferences and goals.

OTHERUsual Care Group

Participants randomized to the usual care group will receive usual care provided by their oncology clinical team. These teams have been trained in symptom assessment, goals-of-care (GoC) discussions, and documentation of such clinical services. As part of usual care, participants may engage in symptom and GoC discussions at any time, initiated by either the patient or the clinician.


Locations(1)

Veterans Affairs Palo Alto Health Care System (VAPAHCS)

Palo Alto, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07219251


Related Trials